Is it time to screen all patients with hypertension for primary aldosteronism? Screening for primary aldosteronism in patients newly diagnosed with hypertension would maximise treatment benefits and minimise end-organ damage

Jun Yang, Peter J Fuller, Michael Stowasser

Research output: Contribution to journalArticleOtherpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)57-59.e1
Number of pages4
JournalThe Medical Journal of Australia
Issue number2
Publication statusPublished - 16 Jul 2018

Cite this